Pharmaceutical logistics transform to handle temperature-sensitive drugs

The increasing prevalence of highly specialized medicines, such as mRNA vaccines, biologics, gene therapies, and GLP-1 preparations, is driving a transformation in pharmaceutical supply chains. These products require strict temperature regulation, as even minor deviations can pose significant quality risks.

To address these complexities, the German Federal Council has called on the federal government to advocate for uniform European requirements for transport service providers. The goal is to ensure that storage and transport temperatures are maintained consistently from the manufacturer to the patient.

For logistics providers, this shift necessitates more than just increased cooling capacity; it requires advanced temperature management, high transparency throughout the entire transport route, and quality management systems capable of meeting diverse regulatory standards, particularly across international borders.